Hologic to Acquire SOMATEX, Leader in Biopsy Site Markers and Localization Technologies, for $64 Million

View source version on?businesswire.com:?https://www.businesswire.com/news/home/20210104005139/en/
Media: Jane Mazur 508.263.8764 (direct) 585.355.5978 (mobile) jane.mazur@hologic.com Investors: Michael Watts 858.410.8588 michael.watts@hologic.com Source: Hologic, Inc.